No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs200150659 |
chr11:58979320-58979321 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs540845788 |
chr11:58979321-58979322 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs182852785 |
chr11:58979322-58979323 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs529935404 |
chr11:58979329-58979330 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs370919527 |
chr11:58979349-58979350 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs377757190 |
chr11:58979368-58979369 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs551486642 |
chr11:58979380-58979381 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs371318082 |
chr11:58979389-58979390 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs11229878 |
chr11:58979393-58979394 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs562894677 |
chr11:58979412-58979413 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs367733685 |
chr11:58979413-58979414 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs370268323 |
chr11:58979425-58979426 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs374800011 |
chr11:58979445-58979446 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs374105942 |
chr11:58979520-58979521 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs397832527 |
chr11:58979530-58979531 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs368175940 |
chr11:58979553-58979554 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs367999964 |
chr11:58979562-58979563 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs372079624 |
chr11:58979565-58979566 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs375135198 |
chr11:58979568-58979569 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs4084080 |
chr11:58979587-58979588 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs551823490 |
chr11:58979597-58979598 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs372290102 |
chr11:58979598-58979599 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs186806583 |
chr11:58979599-58979600 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs191524398 |
chr11:58979606-58979607 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs200053414 |
chr11:58979633-58979634 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs369015266 |
chr11:58979634-58979635 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs200732824 |
chr11:58979641-58979642 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs138151828 |
chr11:58979643-58979644 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs555005923 |
chr11:58979644-58979645 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs576469915 |
chr11:58979659-58979660 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs199564440 |
chr11:58979668-58979669 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs559035712 |
chr11:58979672-58979673 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs566154687 |
chr11:58979673-58979674 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs369379839 |
chr11:58979682-58979683 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs577249718 |
chr11:58979690-58979691 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs373577741 |
chr11:58979693-58979694 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs142542166 |
chr11:58979709-58979710 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs370837054 |
chr11:58979712-58979713 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs76683796 |
chr11:58979722-58979723 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs377486743 |
chr11:58979726-58979727 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs78500826 |
chr11:58979739-58979740 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs370351139 |
chr11:58979748-58979749 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs201984349 |
chr11:58979762-58979763 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs541679679 |
chr11:58979779-58979780 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs200143926 |
chr11:58979794-58979795 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs370491206 |
chr11:58979797-58979798 |
Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs146004268 |
chr11:58979810-58979811 |
Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs530399719 |
chr11:58979830-58979831 |
Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs368341399 |
chr11:58979843-58979844 |
Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs200830689 |
chr11:58979848-58979849 |
Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|